Superantigen-based immunotherapy: a phase I trial of PNU-214565, a monoclonal antibody-staphylococcal enterotoxin A recombinant fusion protein, in advanced pancreatic and colorectal cancer.
Bruce J. Giantonio(Northwestern University), Louis M. Weiner(Georgetown University), C McAleer, B J Shannon(Fox Chase Cancer Center), R. Katherine Alpaugh(Fox Chase Cancer Center), Y. Guédez(Fox Chase Cancer Center), Duane W. Newton, Josephine Schultz(Fox Chase Cancer Center), Libor Vı́tek(Charles University), Malak Kotb(Fox Chase Cancer Center), R. B. R. Persson(Fox Chase Cancer Center), Mikael Dohlsten(Fox Chase Cancer Center), Bertil Persson(Lund University), Per Olov Gunnarsson(Fox Chase Cancer Center), Terje Kalland(Fox Chase Cancer Center)
Cited by 82
Related Papers
Bevacizumab in Combination With Oxaliplatin, Fluorouracil, and Leucovorin (FOLFOX4) for Previously Treated Metastatic Colorectal Cancer: Results From the Eastern Cooperative Oncology Group Study E3200
|Journal of Clinical Oncology|2007|2.3k
The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research
|Clinical Cancer Research|2009|1.4k
Monoclonal Antibodies in Cancer Therapy
|Antibodies|2020|799
Liquid versus tissue biopsy for detecting acquired resistance and tumor heterogeneity in gastrointestinal cancers
|Nature Medicine|2019|521
Minimal Residual Disease Detection using a Plasma-only Circulating Tumor DNA Assay in Patients with Colorectal Cancer
|Clinical Cancer Research|2021|358